Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
| Autor: | Nikoo, Marzieh, Rabiee, Fatemeh, Mohebbi, Hossein, Eghbalifard, Negar, Rajabi, Hamid, Yazdani, Yalda, Sakhaei, Delaram, Khosravifarsani, Mohammadreza, Akhavan-Sigari, Reza |
|---|---|
| Zdroj: | In International Immunopharmacology April 2023 117 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect